Skip to main content
Erschienen in: Cancer Causes & Control 1/2007

01.02.2007 | Review

Trace elements and cancer risk: a review of the epidemiologic evidence

verfasst von: Stephanie A. Navarro Silvera, Thomas E. Rohan

Erschienen in: Cancer Causes & Control | Ausgabe 1/2007

Einloggen, um Zugang zu erhalten

Abstract

Worldwide, there are more than 10 million new cancer cases each year, and cancer is the cause of approximately 12% of all deaths. Given this, a large number of epidemiologic studies have been undertaken to identify potential risk factors for cancer, amongst which the association with trace elements has received considerable attention. Trace elements, such as selenium, zinc, arsenic, cadmium, and nickel, are found naturally in the environment, and human exposure derives from a variety of sources, including air, drinking water, and food. Trace elements are of particular interest given that the levels of exposure to them are potentially modifiable. In this review, we focus largely on the association between each of the trace elements noted above and risk of cancers of the lung, breast, colorectum, prostate, urinary bladder, and stomach. Overall, the evidence currently available appears to support an inverse association between selenium exposure and prostate cancer risk, and possibly also a reduction in risk with respect to lung cancer, although additional prospective studies are needed. There is also limited evidence for an inverse association between zinc and breast cancer, and again, prospective studies are needed to confirm this. Most studies have reported no association between selenium and risk of breast, colorectal, and stomach cancer, and between zinc and prostate cancer risk. There is compelling evidence in support of positive associations between arsenic and risk of both lung and bladder cancers, and between cadmium and lung cancer risk.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55: 74–108PubMed Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55: 74–108PubMed
2.
Zurück zum Zitat World Health Organization (1996) Trace elements in human nutrition and health. World Health Organization, Geneva World Health Organization (1996) Trace elements in human nutrition and health. World Health Organization, Geneva
3.
Zurück zum Zitat Whanger PD (2004) Selenium and its relationship to cancer: an update dagger. Br J Nutr 91:11–28PubMedCrossRef Whanger PD (2004) Selenium and its relationship to cancer: an update dagger. Br J Nutr 91:11–28PubMedCrossRef
4.
5.
Zurück zum Zitat Sattar N, Scott HR, McMillan DC, Talwar D, O’Reilly DSJ, Fell GS (1997) Acute-phase reactants and plasma trace element concentrations in non-small cell lung cancer patients and controls. Nutr Cancer 28:308–312PubMedCrossRef Sattar N, Scott HR, McMillan DC, Talwar D, O’Reilly DSJ, Fell GS (1997) Acute-phase reactants and plasma trace element concentrations in non-small cell lung cancer patients and controls. Nutr Cancer 28:308–312PubMedCrossRef
6.
Zurück zum Zitat Blot WJ, Brown LM, Pottern LM, Stone BJ, Fraumeni Jr JF (1983) Lung cancer among long-term steel workers. Am J Epidemiol 117:706–716PubMed Blot WJ, Brown LM, Pottern LM, Stone BJ, Fraumeni Jr JF (1983) Lung cancer among long-term steel workers. Am J Epidemiol 117:706–716PubMed
7.
8.
Zurück zum Zitat International Agency for Research on Cancer (IARC) (1993) IARC monographs on the evaluation of the carcinogenic risk to man: beryllium, cadmium, mercury, and exposures in the glass manufacturing industry. Working Group views and expert opinions. IARC Press, Lyon International Agency for Research on Cancer (IARC) (1993) IARC monographs on the evaluation of the carcinogenic risk to man: beryllium, cadmium, mercury, and exposures in the glass manufacturing industry. Working Group views and expert opinions. IARC Press, Lyon
9.
Zurück zum Zitat International Agency for Research on Cancer (IARC) (1999) Arsenic and arsenic compounds. Overall evaluations of carcinogenicity: an updating of IARC Monographs Volumes 1 to 42. IARC, Lyon (France). Report No.: Supplement 7 International Agency for Research on Cancer (IARC) (1999) Arsenic and arsenic compounds. Overall evaluations of carcinogenicity: an updating of IARC Monographs Volumes 1 to 42. IARC, Lyon (France). Report No.: Supplement 7
10.
Zurück zum Zitat International Agency for Research on Cancer (IARC) (1990) Chromium, nickel and welding. IARC Monogr Eval Carcinog Risk Chem Man 49:1–648 International Agency for Research on Cancer (IARC) (1990) Chromium, nickel and welding. IARC Monogr Eval Carcinog Risk Chem Man 49:1–648
11.
Zurück zum Zitat Agency for Toxic Substances and Disease Registry (ATSDR) (2003) Toxicological profile for arsenic. United States Department of Health and Human Services Agency for Toxic Substances and Disease Registry, Atlanta, GA, Report No.: 7440-38-2 Agency for Toxic Substances and Disease Registry (ATSDR) (2003) Toxicological profile for arsenic. United States Department of Health and Human Services Agency for Toxic Substances and Disease Registry, Atlanta, GA, Report No.: 7440-38-2
12.
Zurück zum Zitat Rasmussen L, Andersen KJ (2003) Environmental health and human exposure assessment. In: World Health Organization, UNICEF, editors. Arsenic in drinking water. IWA, London, pp 67–168 Rasmussen L, Andersen KJ (2003) Environmental health and human exposure assessment. In: World Health Organization, UNICEF, editors. Arsenic in drinking water. IWA, London, pp 67–168
13.
Zurück zum Zitat Agency for Toxic Substances and Disease Registry (ATSDR) (1999) Toxicological profile for cadmium. United States Department of Health and Human Services Agency for Toxic Substances and Disease Registry, Atlanta, GA, Report No.: 7440-43-9 Agency for Toxic Substances and Disease Registry (ATSDR) (1999) Toxicological profile for cadmium. United States Department of Health and Human Services Agency for Toxic Substances and Disease Registry, Atlanta, GA, Report No.: 7440-43-9
14.
Zurück zum Zitat WHO Regional Office for Europe (2000) Air quality guidelines, 2nd edn. World Health Organization, Copenhagen, Denmark WHO Regional Office for Europe (2000) Air quality guidelines, 2nd edn. World Health Organization, Copenhagen, Denmark
15.
Zurück zum Zitat Agency for Toxic Substances and Disease Registry (ATSDR) (2003) Toxicological profile for nickel. United States Department of Health and Human Services Agency for Toxic Substances and Disease Registry, Atlanta, GA, Report No.: 7440-02-0 Agency for Toxic Substances and Disease Registry (ATSDR) (2003) Toxicological profile for nickel. United States Department of Health and Human Services Agency for Toxic Substances and Disease Registry, Atlanta, GA, Report No.: 7440-02-0
16.
Zurück zum Zitat Lamm SH, Engel A, Kruse MB, et al (2004) Arsenic in drinking water and bladder cancer mortality in the United States: an analysis based on 133 U.S. counties and 30 years of observation. J Occup Environ Med 46:298–306PubMedCrossRef Lamm SH, Engel A, Kruse MB, et al (2004) Arsenic in drinking water and bladder cancer mortality in the United States: an analysis based on 133 U.S. counties and 30 years of observation. J Occup Environ Med 46:298–306PubMedCrossRef
17.
Zurück zum Zitat Agency for Toxic Substances, Disease Registry (ATSDR) (2003) Toxicological profile for zinc. United States Department of Health and Human Services Agency for Toxic Substances and Disease Registry, Atlanta, GA, Report No.: 7440-66-6 Agency for Toxic Substances, Disease Registry (ATSDR) (2003) Toxicological profile for zinc. United States Department of Health and Human Services Agency for Toxic Substances and Disease Registry, Atlanta, GA, Report No.: 7440-66-6
18.
Zurück zum Zitat Agency for Toxic Substances and Disease Registry (ATSDR) (2003) Toxicological profile for selenium. United States Department of Health and Human Services Agency for Toxic Substances and Disease Registry, Atlanta, GA, Report No.: 7782-49-2 Agency for Toxic Substances and Disease Registry (ATSDR) (2003) Toxicological profile for selenium. United States Department of Health and Human Services Agency for Toxic Substances and Disease Registry, Atlanta, GA, Report No.: 7782-49-2
19.
Zurück zum Zitat Abdulla M, Parr RM, Iyengar GV (1993) Trace element requirements, intake and recommendations. In: Prasad AS (eds) Essential and toxic trace elements in human health and disease: an update. Wiley-Liss, New York, pp 311–328 Abdulla M, Parr RM, Iyengar GV (1993) Trace element requirements, intake and recommendations. In: Prasad AS (eds) Essential and toxic trace elements in human health and disease: an update. Wiley-Liss, New York, pp 311–328
20.
Zurück zum Zitat Hunter, D, Morris, JS, Chute, CG, et al. 1990Predictors of selenium concentration in human toenailsAm J Epidemiol132114122PubMed Hunter, D, Morris, JS, Chute, CG,  et al. 1990Predictors of selenium concentration in human toenailsAm J Epidemiol132114122PubMed
21.
Zurück zum Zitat Burguera JL, Burguera M, Gallignani M, Alarcon OM, Burguera JA (1990) Blood serum selenium in the province of Merida, Venezuela, related to sex, cancer incidence, and soil selenium contnet. J Trace Elem Electrolytes Health Dis 4:73–77PubMed Burguera JL, Burguera M, Gallignani M, Alarcon OM, Burguera JA (1990) Blood serum selenium in the province of Merida, Venezuela, related to sex, cancer incidence, and soil selenium contnet. J Trace Elem Electrolytes Health Dis 4:73–77PubMed
22.
Zurück zum Zitat Agency for Toxic Substances and Disease Registry (ATSDR) (2001) ToxFAQs. U.S. Department of Health and Human Services, Public Health Service, Atlanta, GA Agency for Toxic Substances and Disease Registry (ATSDR) (2001) ToxFAQs. U.S. Department of Health and Human Services, Public Health Service, Atlanta, GA
23.
Zurück zum Zitat Meyer F, Verreault R (1987) Erythrocyte selemium and breast cancer risk. Am J Epidemiol 125:917–919PubMed Meyer F, Verreault R (1987) Erythrocyte selemium and breast cancer risk. Am J Epidemiol 125:917–919PubMed
24.
Zurück zum Zitat Garland M, Morris JS, Rosner B, et al (1993) Toenail trace element levels as biomarkers: reproducibility over a 6-year period. Cancer Epidemiol Biomarkers Prev 2:493–497 Garland M, Morris JS, Rosner B, et al (1993) Toenail trace element levels as biomarkers: reproducibility over a 6-year period. Cancer Epidemiol Biomarkers Prev 2:493–497
25.
Zurück zum Zitat Swanson CA, Longnecker MP, Veillon C, et al (1990) Selenium intake, age, gender, and smoking in relation to indices of selenium status of adults residing in seleniferous area. Am J Clin Nutr 52:858–862PubMed Swanson CA, Longnecker MP, Veillon C, et al (1990) Selenium intake, age, gender, and smoking in relation to indices of selenium status of adults residing in seleniferous area. Am J Clin Nutr 52:858–862PubMed
26.
Zurück zum Zitat Longnecker MP, Stram DO, Taylor PA, et al (1996) Use of selenium concentration in whole blood, serum, toenails, or urine as a surrogate measure of selenium intake. Epidemiol 7:384–390 Longnecker MP, Stram DO, Taylor PA, et al (1996) Use of selenium concentration in whole blood, serum, toenails, or urine as a surrogate measure of selenium intake. Epidemiol 7:384–390
27.
Zurück zum Zitat Agahian B, Lee JS, Nelson JH, John RE (1990) Arsenic levels in fingernails as a biological indicator of exposure to arsenic. Am Ind Hyg Assoc J 51:646–651PubMed Agahian B, Lee JS, Nelson JH, John RE (1990) Arsenic levels in fingernails as a biological indicator of exposure to arsenic. Am Ind Hyg Assoc J 51:646–651PubMed
28.
Zurück zum Zitat King JC (1990) Assessment of zinc status. J Nutr 120:1474–1479PubMed King JC (1990) Assessment of zinc status. J Nutr 120:1474–1479PubMed
29.
Zurück zum Zitat Wood RJ (2000) Assessment of marginal zinc status in humans. J Nutr 130:1350S–1354SPubMed Wood RJ (2000) Assessment of marginal zinc status in humans. J Nutr 130:1350S–1354SPubMed
30.
Zurück zum Zitat Nielsen FH (1993) Ultratrace elements of possible importance for human health: an update. In: Prasad AS (eds) Essential and toxic trace elements in human health and disease: an update. Wiley-Liss, New York, pp 355–376 Nielsen FH (1993) Ultratrace elements of possible importance for human health: an update. In: Prasad AS (eds) Essential and toxic trace elements in human health and disease: an update. Wiley-Liss, New York, pp 355–376
31.
Zurück zum Zitat Uthus EO, Seaborn CD (1996) Deliberations and evaluations of the approaches, endpoints and paradigms for dietary recommendations of the other trace elements. J Nutr 126:2452S–2459SPubMed Uthus EO, Seaborn CD (1996) Deliberations and evaluations of the approaches, endpoints and paradigms for dietary recommendations of the other trace elements. J Nutr 126:2452S–2459SPubMed
32.
Zurück zum Zitat Leonard A, Gerber GB (1994) Mutagenicity, carcinogenicity and teratogenicity of vanadium compounds. Mutat Res 317:81–88PubMed Leonard A, Gerber GB (1994) Mutagenicity, carcinogenicity and teratogenicity of vanadium compounds. Mutat Res 317:81–88PubMed
33.
Zurück zum Zitat Hossain K, Akhand AA, Kato M, et al (2000) Arsenite induces apoptosis of murine T lymphocytes through membrane raft-linked signaling for activation of c-Jun amino-terminal kinase. J Immunol 165:4290–4297PubMed Hossain K, Akhand AA, Kato M, et al (2000) Arsenite induces apoptosis of murine T lymphocytes through membrane raft-linked signaling for activation of c-Jun amino-terminal kinase. J Immunol 165:4290–4297PubMed
34.
Zurück zum Zitat Chen W, Martindale JL, Holbrook NJ, Liu Y (1998) Tumor promoter arsenite activates extracellular signal-regulated kinase through a signaling pathway mediated by epidermal growth factor receptor and Shc. Mol Cell Biol 18:5178–5188PubMed Chen W, Martindale JL, Holbrook NJ, Liu Y (1998) Tumor promoter arsenite activates extracellular signal-regulated kinase through a signaling pathway mediated by epidermal growth factor receptor and Shc. Mol Cell Biol 18:5178–5188PubMed
35.
Zurück zum Zitat Office of Environmental Health Hazard Assessment (2004) Public health goal for arsenic in drinking water. California Environmental Protection Agency Office of Environmental Health Hazard Assessment (2004) Public health goal for arsenic in drinking water. California Environmental Protection Agency
36.
Zurück zum Zitat Bates MN, Smith AH, Hopenhayn-Rich C (1992) Arsenic ingestion and internal cancers: a review. Am J Epidemiol 135:462–476PubMed Bates MN, Smith AH, Hopenhayn-Rich C (1992) Arsenic ingestion and internal cancers: a review. Am J Epidemiol 135:462–476PubMed
37.
Zurück zum Zitat Chen CJ, Chuang YC, You SL, Lin HY (1986) A retrospective study on malignant neoplasms of bladder, lung and liver in blackfoot disease endemic area in Taiwan. Br J Cancer 53:399–405PubMed Chen CJ, Chuang YC, You SL, Lin HY (1986) A retrospective study on malignant neoplasms of bladder, lung and liver in blackfoot disease endemic area in Taiwan. Br J Cancer 53:399–405PubMed
38.
Zurück zum Zitat Ferreccio C, Gonzalez PC, Milosavjlevic SV, Marshall GG, Sancha AM, Smith AH (2000) Lung cancer and arsenic concentrations in drinking water in Chile. Epidemiology 11:673–679PubMedCrossRef Ferreccio C, Gonzalez PC, Milosavjlevic SV, Marshall GG, Sancha AM, Smith AH (2000) Lung cancer and arsenic concentrations in drinking water in Chile. Epidemiology 11:673–679PubMedCrossRef
39.
Zurück zum Zitat Chiou HY, Hsueh YM, Liaw KF, et al (1995) Incidence of internal cancers and ingested inorganic arsenic: a seven-year follow-up study in Taiwan. Cancer Res 55:1296–1300PubMed Chiou HY, Hsueh YM, Liaw KF, et al (1995) Incidence of internal cancers and ingested inorganic arsenic: a seven-year follow-up study in Taiwan. Cancer Res 55:1296–1300PubMed
40.
Zurück zum Zitat Chen Y, Ahsan H (2004) Cancer burden from arsenic in drinking water in Bangladesh. Am J Public Health 94:741–744PubMed Chen Y, Ahsan H (2004) Cancer burden from arsenic in drinking water in Bangladesh. Am J Public Health 94:741–744PubMed
41.
Zurück zum Zitat Lewis DR, Southwick JW, Ouellet-Hellstrom R, Rench J, Calderon RJ (1999) Drinking water arsenic in Utah: A cohort mortality study. Environ Health Perspect 107:359–365PubMed Lewis DR, Southwick JW, Ouellet-Hellstrom R, Rench J, Calderon RJ (1999) Drinking water arsenic in Utah: A cohort mortality study. Environ Health Perspect 107:359–365PubMed
42.
Zurück zum Zitat Bates MN, Rey OA, Biggs ML, et al (2004) Case–control study of bladder cancer and exposure to arsenic in Argentina. Am J Epidemiology 159:381–389CrossRef Bates MN, Rey OA, Biggs ML, et al (2004) Case–control study of bladder cancer and exposure to arsenic in Argentina. Am J Epidemiology 159:381–389CrossRef
43.
Zurück zum Zitat Chiou HY, Chiou ST, Hsu YH, et al (2001) Incidence of transitional cell carcinoma and arsenic in drinking water: a follow-up study of 8,102 residents in an arseniasis-endemic area in northeastern Taiwan. Am J Epidemiol 153:411–418PubMedCrossRef Chiou HY, Chiou ST, Hsu YH, et al (2001) Incidence of transitional cell carcinoma and arsenic in drinking water: a follow-up study of 8,102 residents in an arseniasis-endemic area in northeastern Taiwan. Am J Epidemiol 153:411–418PubMedCrossRef
44.
Zurück zum Zitat Kurttio P, Pukkala E, Kahelin A, Auvinen A, Pekkanen J (1999) Arsenic concentrations in well water and risk of bladder and kidney cancer in Finland. Environ Health Perspect 107:705–710PubMed Kurttio P, Pukkala E, Kahelin A, Auvinen A, Pekkanen J (1999) Arsenic concentrations in well water and risk of bladder and kidney cancer in Finland. Environ Health Perspect 107:705–710PubMed
45.
Zurück zum Zitat Garland M, Morris JS, Colditz GA, et al (1996) Toenail trace element levels and breast cancer: a prospective study. Am J Epidemiol 144:653–660PubMed Garland M, Morris JS, Colditz GA, et al (1996) Toenail trace element levels and breast cancer: a prospective study. Am J Epidemiol 144:653–660PubMed
46.
Zurück zum Zitat Pershagen G (1985) Lung cancer mortality among men living near an arsenic-emitting smelter. Am J Epidemiology 122:684–694 Pershagen G (1985) Lung cancer mortality among men living near an arsenic-emitting smelter. Am J Epidemiology 122:684–694
47.
Zurück zum Zitat Hazelton WD, Leubeck EG, Heidenreich WF, Moolgavkar SH (2001) Analysis of a historical cohort of Chinese tin miners with arsenic, radon, cigarette smoke, and pipe smoke exposures using the biologically based two-stage clonal expansion model. Radiation Research 156:78–94PubMedCrossRef Hazelton WD, Leubeck EG, Heidenreich WF, Moolgavkar SH (2001) Analysis of a historical cohort of Chinese tin miners with arsenic, radon, cigarette smoke, and pipe smoke exposures using the biologically based two-stage clonal expansion model. Radiation Research 156:78–94PubMedCrossRef
48.
Zurück zum Zitat Mabuchi K, Lilienfeld AM, Snell LM (1980) Cancer and occupational exposure to arsenic: a study of pesticide workers. Prev Med 9:51–77PubMedCrossRef Mabuchi K, Lilienfeld AM, Snell LM (1980) Cancer and occupational exposure to arsenic: a study of pesticide workers. Prev Med 9:51–77PubMedCrossRef
49.
Zurück zum Zitat Coggon D, Pannett B, Acheson ED (1984) Use of job-exposure matrix in an occupational analysis of lung and bladder cancers on the basis of death certificates. JNCI 72:61–65PubMed Coggon D, Pannett B, Acheson ED (1984) Use of job-exposure matrix in an occupational analysis of lung and bladder cancers on the basis of death certificates. JNCI 72:61–65PubMed
50.
Zurück zum Zitat Bates MN, Smith AH, Cantor KP (1995) Case–control study of bladder cancer and arsenic in drinking water. Am J Epidemiology 141:523–530 Bates MN, Smith AH, Cantor KP (1995) Case–control study of bladder cancer and arsenic in drinking water. Am J Epidemiology 141:523–530
51.
Zurück zum Zitat Steinmaus C, Yuan Y, Bates MN, Smith AH (2003) Case–control study of bladder cancer and drinking water arsenic in the western United States. Am J Epidemiol 158:1193–1201PubMedCrossRef Steinmaus C, Yuan Y, Bates MN, Smith AH (2003) Case–control study of bladder cancer and drinking water arsenic in the western United States. Am J Epidemiol 158:1193–1201PubMedCrossRef
52.
Zurück zum Zitat Michaud DS, Wright ME, Cantor KP, Taylor PR, Virtamo J, Albanes D (2004) Arsenic concentrations in prediagnostic toenails and the risk of bladder cancer in a cohort of male smokers. Am J Epidemiol 160:835–859CrossRef Michaud DS, Wright ME, Cantor KP, Taylor PR, Virtamo J, Albanes D (2004) Arsenic concentrations in prediagnostic toenails and the risk of bladder cancer in a cohort of male smokers. Am J Epidemiol 160:835–859CrossRef
53.
Zurück zum Zitat U.S. Department of Health and Human Services, Public Health Service, National Toxicology Program (2002) Report on Carcinogens, 10th edn. 2002 December U.S. Department of Health and Human Services, Public Health Service, National Toxicology Program (2002) Report on Carcinogens, 10th edn. 2002 December
54.
Zurück zum Zitat McMurray CT, Tainer JA (2003) Cancer, cadmium and genome integrity. Nature Genetics 34:239–241PubMedCrossRef McMurray CT, Tainer JA (2003) Cancer, cadmium and genome integrity. Nature Genetics 34:239–241PubMedCrossRef
55.
Zurück zum Zitat Waalkes MP (2000) Cadmium carcinogenesis in review. J Inorg Chem 79:241–244 Waalkes MP (2000) Cadmium carcinogenesis in review. J Inorg Chem 79:241–244
56.
Zurück zum Zitat Zheng H, Liu J, Choo KH, Michalska AE, Klaassen CD (1996) Metallothionein-I and -II knock-out mice are sensitive to cadmium-induced liver mRNA expression of c-jun and p53. Toxicol Appl Pharmacol 136:229–235PubMedCrossRef Zheng H, Liu J, Choo KH, Michalska AE, Klaassen CD (1996) Metallothionein-I and -II knock-out mice are sensitive to cadmium-induced liver mRNA expression of c-jun and p53. Toxicol Appl Pharmacol 136:229–235PubMedCrossRef
57.
Zurück zum Zitat Abshire MK, Buzard GS, Shiraishi N, Waalkes MP (1996) Induction of c-myc and c-jun proto-oncogene expression in rat L6 myoblasts by cadmium is inhibited by zinc preinduction of the metallothionein gene. J Toxicol Environ Health 48:359–377PubMedCrossRef Abshire MK, Buzard GS, Shiraishi N, Waalkes MP (1996) Induction of c-myc and c-jun proto-oncogene expression in rat L6 myoblasts by cadmium is inhibited by zinc preinduction of the metallothionein gene. J Toxicol Environ Health 48:359–377PubMedCrossRef
58.
Zurück zum Zitat Shimada H, Shiao YH, Shibata M, Waalkes MP (1998) Cadmium suppresses apoptosis induced by chromium. J Toxicol Environ Health 54:159–168CrossRef Shimada H, Shiao YH, Shibata M, Waalkes MP (1998) Cadmium suppresses apoptosis induced by chromium. J Toxicol Environ Health 54:159–168CrossRef
59.
Zurück zum Zitat Lemen RA, Lee JS, Wagoner JK, Blejer HP (1976) Cancer mortality among cadmium production workers. Ann NY Acad Sci 271:273–279PubMedCrossRef Lemen RA, Lee JS, Wagoner JK, Blejer HP (1976) Cancer mortality among cadmium production workers. Ann NY Acad Sci 271:273–279PubMedCrossRef
60.
Zurück zum Zitat Sorahan T, Watherhouse JAH (1983) Mortality study of nickel–cadmium battery workers by the method of regression models in life tables. Br J Ind Med 40:293–300PubMed Sorahan T, Watherhouse JAH (1983) Mortality study of nickel–cadmium battery workers by the method of regression models in life tables. Br J Ind Med 40:293–300PubMed
61.
Zurück zum Zitat Elinder CG, Kjellstrom T, Hogstedt C, Andersson K, Spang G (1985) Cancer mortality of cadmium workers. Br J Ind Med 42:651–655PubMed Elinder CG, Kjellstrom T, Hogstedt C, Andersson K, Spang G (1985) Cancer mortality of cadmium workers. Br J Ind Med 42:651–655PubMed
62.
Zurück zum Zitat Sorahan T (1987) Mortality from lung cancer among a cohort of nickel cadmium battery workers: 1946–84. Br J Ind Med 44:803–809PubMed Sorahan T (1987) Mortality from lung cancer among a cohort of nickel cadmium battery workers: 1946–84. Br J Ind Med 44:803–809PubMed
63.
Zurück zum Zitat Kazantzis G, Lam TH, Sullivan KR (1988) Mortality of cadmium-exposed workers. Scand J Work Environ Health 14:220–223PubMed Kazantzis G, Lam TH, Sullivan KR (1988) Mortality of cadmium-exposed workers. Scand J Work Environ Health 14:220–223PubMed
64.
Zurück zum Zitat Stayner L, Smith R, Thun M, Schnorr T, Lemen R (1992) A dose-response analysis and quantitative assessment of lung cancer risk and occupational cadmium exposure. Ann Epidemiol 2:177–194PubMedCrossRef Stayner L, Smith R, Thun M, Schnorr T, Lemen R (1992) A dose-response analysis and quantitative assessment of lung cancer risk and occupational cadmium exposure. Ann Epidemiol 2:177–194PubMedCrossRef
65.
Zurück zum Zitat Sorahan T, Lister A, Gilthorpe MS, Harrington JM (1995) Mortality of copper cadmium alloy workers with special reference to lung cancer and non-malignant diseases of the respiratory system, 1946–92. Occup Environ Med 52:804–812PubMed Sorahan T, Lister A, Gilthorpe MS, Harrington JM (1995) Mortality of copper cadmium alloy workers with special reference to lung cancer and non-malignant diseases of the respiratory system, 1946–92. Occup Environ Med 52:804–812PubMed
66.
Zurück zum Zitat West DW, Slattery ML, Robison LM, French TK, Mahoney AW (1991) Adult dietary intake and prostate cancer risk in Utah: a case–control study with special emphasis on aggressive tumors. Cancer Causes Control 2:85–94PubMedCrossRef West DW, Slattery ML, Robison LM, French TK, Mahoney AW (1991) Adult dietary intake and prostate cancer risk in Utah: a case–control study with special emphasis on aggressive tumors. Cancer Causes Control 2:85–94PubMedCrossRef
67.
Zurück zum Zitat Platz EA, Helzlsouer KJ, Hoffman SC, Morris JS, Baskett CK, Comstock GW (2002) Prediagnostic toenail cadmium and zinc and subsequent prostate cancer risk. Prostate 52:288–296PubMedCrossRef Platz EA, Helzlsouer KJ, Hoffman SC, Morris JS, Baskett CK, Comstock GW (2002) Prediagnostic toenail cadmium and zinc and subsequent prostate cancer risk. Prostate 52:288–296PubMedCrossRef
68.
Zurück zum Zitat Armstrong BG, Kazantzis G (1985) Prostatic cancer and chronic respiratory and renal disease in British cadmium workers: a case–control study. Br J Ind Med 42:540–545PubMed Armstrong BG, Kazantzis G (1985) Prostatic cancer and chronic respiratory and renal disease in British cadmium workers: a case–control study. Br J Ind Med 42:540–545PubMed
69.
Zurück zum Zitat Miki H, Kasprzak KS, Kenney S, Heine UI (1987) Inhibition of intercellular communication by nickel (II): antagonistic effect of magnesium. Carcinogensis 8:1757–1760 Miki H, Kasprzak KS, Kenney S, Heine UI (1987) Inhibition of intercellular communication by nickel (II): antagonistic effect of magnesium. Carcinogensis 8:1757–1760
70.
Zurück zum Zitat DiPaolo JA, Casto BC (1979) Quantitative studies of in vitro morphological transformation of Syrian hamster cells by inorganic metal salts. Cancer Res 39:1008–1013PubMed DiPaolo JA, Casto BC (1979) Quantitative studies of in vitro morphological transformation of Syrian hamster cells by inorganic metal salts. Cancer Res 39:1008–1013PubMed
71.
Zurück zum Zitat Biedermann KA, Landolph JT (1987) Induction of anchorage independence in human diploid foreskin fibroblasts by carcinogenic metal salts. Cancer Res 47:3815–3823PubMed Biedermann KA, Landolph JT (1987) Induction of anchorage independence in human diploid foreskin fibroblasts by carcinogenic metal salts. Cancer Res 47:3815–3823PubMed
72.
Zurück zum Zitat Patierno SR, Dirscherl L, Xu J (1993) Transformation of rat tracheal epithelial cells to immortal growth variants by particulate and soluble nickel compounds. Mutat Res 300:179–193PubMedCrossRef Patierno SR, Dirscherl L, Xu J (1993) Transformation of rat tracheal epithelial cells to immortal growth variants by particulate and soluble nickel compounds. Mutat Res 300:179–193PubMedCrossRef
73.
Zurück zum Zitat Costa M (1996) Mehcanisms of nickel genotoxicity and carcinogenicity. In: Chang LW (eds) Toxicology of metals. CRC Press, Boca Raton, FL, pp 245–251 Costa M (1996) Mehcanisms of nickel genotoxicity and carcinogenicity. In: Chang LW (eds) Toxicology of metals. CRC Press, Boca Raton, FL, pp 245–251
74.
Zurück zum Zitat Sen P, Conway K, Costa M (1987) Comparison of the localization of chromosome damage induced by calcium chromate and nickel compounds. Cancer Res 47:2142–2147PubMed Sen P, Conway K, Costa M (1987) Comparison of the localization of chromosome damage induced by calcium chromate and nickel compounds. Cancer Res 47:2142–2147PubMed
75.
Zurück zum Zitat Kasprzak KS (1991) The role of oxidative damage in metal carcinogenicity. Chem Res Toxicol 4:604–615PubMedCrossRef Kasprzak KS (1991) The role of oxidative damage in metal carcinogenicity. Chem Res Toxicol 4:604–615PubMedCrossRef
76.
Zurück zum Zitat Hartwig A, Mullenders LHF, Schlepegrell R, Kasten U, Beyersmann D (1994) Nickel (II) interferes with the incision step in nucleotide excision repair in mammalian cells. Cancer Res 54:4045–4051PubMed Hartwig A, Mullenders LHF, Schlepegrell R, Kasten U, Beyersmann D (1994) Nickel (II) interferes with the incision step in nucleotide excision repair in mammalian cells. Cancer Res 54:4045–4051PubMed
77.
Zurück zum Zitat Lee YW, Klein CB, Kargacin B, et al (1995) Carcinogenic nickel silences gene expression by chromatin condensation and DNA methylation: a new model for epigenetic carcinogens. Mol Cell Biol 15:2547–2557PubMed Lee YW, Klein CB, Kargacin B, et al (1995) Carcinogenic nickel silences gene expression by chromatin condensation and DNA methylation: a new model for epigenetic carcinogens. Mol Cell Biol 15:2547–2557PubMed
78.
Zurück zum Zitat Grimsrud TK, Berge SR, Haldorsen T, Andersen A (2002) Exposure to different forms of nickel and risk of lung cancer. Am J Epidemiol 156:1123–1132PubMedCrossRef Grimsrud TK, Berge SR, Haldorsen T, Andersen A (2002) Exposure to different forms of nickel and risk of lung cancer. Am J Epidemiol 156:1123–1132PubMedCrossRef
79.
Zurück zum Zitat Grimsrud TK, Berge SR, Martinsen JI, Andersen A (2003) Lung cancer incidence among Norwegian nickel-refinery workers 1953–2000. J Environ Monit 5:190–197PubMedCrossRef Grimsrud TK, Berge SR, Martinsen JI, Andersen A (2003) Lung cancer incidence among Norwegian nickel-refinery workers 1953–2000. J Environ Monit 5:190–197PubMedCrossRef
80.
Zurück zum Zitat Karjalainen S, Kerttula R, Pukkala E (1992) Cancer risk among workers at a copper/nickel smelter and nickel refinery in Finland. Int Arch Occup Environ Health 63:547–551PubMedCrossRef Karjalainen S, Kerttula R, Pukkala E (1992) Cancer risk among workers at a copper/nickel smelter and nickel refinery in Finland. Int Arch Occup Environ Health 63:547–551PubMedCrossRef
81.
Zurück zum Zitat Pang, D, Burges, DCL, Sorahan, T 1996Mortality study of nickel platers with special reference to cancers of the stomach and lung, 1945–93Occup Environ Med53714717PubMed Pang, D, Burges, DCL, Sorahan, T 1996Mortality study of nickel platers with special reference to cancers of the stomach and lung, 1945–93Occup Environ Med53714717PubMed
82.
Zurück zum Zitat Jarup L, Bellander T, Hogstedt C, Spang G (1998) Mortality and cancer incidence in Swedish battery workers exposed to cadmium and nickel. Occup Environ Med 55:755–759PubMed Jarup L, Bellander T, Hogstedt C, Spang G (1998) Mortality and cancer incidence in Swedish battery workers exposed to cadmium and nickel. Occup Environ Med 55:755–759PubMed
83.
Zurück zum Zitat Andersen A, Berge SR, Engeland A, Norseth T (1996) Exposure to nickel compounds and smoking in relation to incidence of lung and nasal cancer among nickel refinery workers. Occup Environ Med 53:708–713PubMed Andersen A, Berge SR, Engeland A, Norseth T (1996) Exposure to nickel compounds and smoking in relation to incidence of lung and nasal cancer among nickel refinery workers. Occup Environ Med 53:708–713PubMed
84.
Zurück zum Zitat Goldhaber SB (2003) Trace element risk assessment: essentiality vs. toxicity. Regul Toxicol Pharmacol 38:232–242PubMedCrossRef Goldhaber SB (2003) Trace element risk assessment: essentiality vs. toxicity. Regul Toxicol Pharmacol 38:232–242PubMedCrossRef
85.
Zurück zum Zitat van’t Veer P, van der Wielen RP, Kok F, Hermus RJ, Sturmans F (1990) Selenium in diet, blood and toenails in relation to breast cancer: a case–control study. Am J Epidemiol 131:987–994 van’t Veer P, van der Wielen RP, Kok F, Hermus RJ, Sturmans F (1990) Selenium in diet, blood and toenails in relation to breast cancer: a case–control study. Am J Epidemiol 131:987–994
86.
Zurück zum Zitat van’t Veer P, Strain JJ, Fernandez-Crehuet J, et al (1996) Tissue antioxidants and postmenopausal breast cancer: the European Community Multicentre Study on Antioxidants, Myocardial Infarction, and Cancer of the Breast (EURAMIC). Cancer Epidemiol Biomark Prev 5:441–447 van’t Veer P, Strain JJ, Fernandez-Crehuet J, et al (1996) Tissue antioxidants and postmenopausal breast cancer: the European Community Multicentre Study on Antioxidants, Myocardial Infarction, and Cancer of the Breast (EURAMIC). Cancer Epidemiol Biomark Prev 5:441–447
87.
Zurück zum Zitat Ghadirian P, Maisonneuve P, Perret C, et al (2000) A case-control study of toenail selenium and cancer of the breast, colon, and prostate. Cancer Detection Prev 24: 305–313 Ghadirian P, Maisonneuve P, Perret C, et al (2000) A case-control study of toenail selenium and cancer of the breast, colon, and prostate. Cancer Detection Prev 24: 305–313
88.
Zurück zum Zitat van Noord PA, de Waard F, Collette C, Mass MJ (1987) Selenium levels in nails of premenopausal breast cancer patients assessed prediagnostically in a cohort-nested case-referent study among women screened in the DOM project. Int J Epidemiol 16: 318–322PubMed van Noord PA, de Waard F, Collette C, Mass MJ (1987) Selenium levels in nails of premenopausal breast cancer patients assessed prediagnostically in a cohort-nested case-referent study among women screened in the DOM project. Int J Epidemiol 16: 318–322PubMed
89.
Zurück zum Zitat Hunter DJ, Morris JS, Stampfer MJ, Colditz GA, Speizer FE, Willett WC (1990) A prospective study of selenium status and breast cancer risk. JAMA 264:1128–1131PubMedCrossRef Hunter DJ, Morris JS, Stampfer MJ, Colditz GA, Speizer FE, Willett WC (1990) A prospective study of selenium status and breast cancer risk. JAMA 264:1128–1131PubMedCrossRef
90.
Zurück zum Zitat van den Brandt PA, Goldbohm RA, van’t Veer P, et al (1994) Toenail selenium and risk of breast cancer. Am J Epidemiol 140:20–26PubMed van den Brandt PA, Goldbohm RA, van’t Veer P, et al (1994) Toenail selenium and risk of breast cancer. Am J Epidemiol 140:20–26PubMed
91.
Zurück zum Zitat Strain JJ, Bokje E, van’t Veer P, et al (1997) Thyroid hormones and selenium status in breast cancer. Nutr Cancer 27:48–52PubMed Strain JJ, Bokje E, van’t Veer P, et al (1997) Thyroid hormones and selenium status in breast cancer. Nutr Cancer 27:48–52PubMed
92.
Zurück zum Zitat Coates RJ, Weiss NS, Daling JR, Morris JS, Labbe RF (1988) Serum levels of selenium and retinol and the subsequent risk of cancer. Am J Epidemiol 128:515–523PubMed Coates RJ, Weiss NS, Daling JR, Morris JS, Labbe RF (1988) Serum levels of selenium and retinol and the subsequent risk of cancer. Am J Epidemiol 128:515–523PubMed
93.
Zurück zum Zitat Schrauzer GN, Molenaar T, Mead S, Kuehn K, Yamamoto H, Araki E (1985) Selenium in the blood of Japanese and American women with and without breast cancer and fibrocystic disease. Jpn J Cancer Res 76:374–377PubMed Schrauzer GN, Molenaar T, Mead S, Kuehn K, Yamamoto H, Araki E (1985) Selenium in the blood of Japanese and American women with and without breast cancer and fibrocystic disease. Jpn J Cancer Res 76:374–377PubMed
94.
Zurück zum Zitat Willett WC, Polk BF, Morris JS, et al (1983) Prediagnostic serum selenium and risk of cancer. Lancet 2:130–134PubMedCrossRef Willett WC, Polk BF, Morris JS, et al (1983) Prediagnostic serum selenium and risk of cancer. Lancet 2:130–134PubMedCrossRef
95.
Zurück zum Zitat Longnecker MP, Stampfer MJ, Morris JS, et al (1993) A 1-y trial of the effect of high-selenium bread on selenium concentrations in blood and toenails. Am J Clin Nutr 57:408–413PubMed Longnecker MP, Stampfer MJ, Morris JS, et al (1993) A 1-y trial of the effect of high-selenium bread on selenium concentrations in blood and toenails. Am J Clin Nutr 57:408–413PubMed
96.
Zurück zum Zitat Morris JS, Stampfer MJ, Willett WC (1983) Dietary selenium in humans. Toenails as an indicator. Biol Trace Elem Res 5:529–537 Morris JS, Stampfer MJ, Willett WC (1983) Dietary selenium in humans. Toenails as an indicator. Biol Trace Elem Res 5:529–537
97.
Zurück zum Zitat Clark LC, Hixson LJ, Combs GF Jr, Reid ME, Turnbull BW, Sampliner RE (1993) Plasma selenium concentration predicts the prevalence of colorectal adenomatous polyps. Cancer Epidemiol Biomark Prev 2:41–46 Clark LC, Hixson LJ, Combs GF Jr, Reid ME, Turnbull BW, Sampliner RE (1993) Plasma selenium concentration predicts the prevalence of colorectal adenomatous polyps. Cancer Epidemiol Biomark Prev 2:41–46
98.
Zurück zum Zitat Fernandez-Banares F, Cabre E, Esteve M, et al (2002) Serum selenium and risk of large size colorectal adenomas in a geographical area with a low selenium status. Am J Gastroenterol 97:2103–2108PubMed Fernandez-Banares F, Cabre E, Esteve M, et al (2002) Serum selenium and risk of large size colorectal adenomas in a geographical area with a low selenium status. Am J Gastroenterol 97:2103–2108PubMed
99.
Zurück zum Zitat Nomura A, Heilbrun LK, Morris JS, Stemmermann GN (1987) Serum selenium and the risk of cancer, by specific sites: case–control analysis of prospective data. JNCI 79:103–108PubMed Nomura A, Heilbrun LK, Morris JS, Stemmermann GN (1987) Serum selenium and the risk of cancer, by specific sites: case–control analysis of prospective data. JNCI 79:103–108PubMed
100.
Zurück zum Zitat Wallace K, Byers T, Morris JS, et al (2003) Prediagnostic serum selenium concentration and the risk of recurrent colorectal adenoma: a nested case–controls study. Cancer Epidemiol Biomark Prev 12:464–467 Wallace K, Byers T, Morris JS, et al (2003) Prediagnostic serum selenium concentration and the risk of recurrent colorectal adenoma: a nested case–controls study. Cancer Epidemiol Biomark Prev 12:464–467
101.
Zurück zum Zitat Garland M, Morris JS, Stampfer MJ, et al (1995) Prospective study of toenail selenium levels and cancer among women. J Natl Cancer Inst 87:497–505PubMed Garland M, Morris JS, Stampfer MJ, et al (1995) Prospective study of toenail selenium levels and cancer among women. J Natl Cancer Inst 87:497–505PubMed
102.
Zurück zum Zitat Mannisto S, Alfthan G, Virtanen M, Kataja V, Uusitupa M, Pietinen P (2000) Toenail selenium and breast cancer – a case–control study in Finland. Eur J Clin Nutr 54:98–103PubMedCrossRef Mannisto S, Alfthan G, Virtanen M, Kataja V, Uusitupa M, Pietinen P (2000) Toenail selenium and breast cancer – a case–control study in Finland. Eur J Clin Nutr 54:98–103PubMedCrossRef
103.
Zurück zum Zitat van den Brandt PA, Goldbohm RA, van’t Veer P, et al (1993) A prospective cohort study on toenail selenium levels and risk of gastrointestinal cancer. JNCI 85:224–229PubMed van den Brandt PA, Goldbohm RA, van’t Veer P, et al (1993) A prospective cohort study on toenail selenium levels and risk of gastrointestinal cancer. JNCI 85:224–229PubMed
104.
Zurück zum Zitat Kabuto M, Imai H, Yonezawa C, et al (1994) Prediagnostic serum selenium and zinc levels and subsequent risk of lung and stomach cancer in Japan. Cancer Epidemiol Biomark Prev 3:465–469 Kabuto M, Imai H, Yonezawa C, et al (1994) Prediagnostic serum selenium and zinc levels and subsequent risk of lung and stomach cancer in Japan. Cancer Epidemiol Biomark Prev 3:465–469
105.
Zurück zum Zitat Ratnasinghe D, Tangrea JA, Forman MR, et al (2000) Serum tocopherols, selenium and lung cancer risk among tin miners in China. Cancer Causes Control 11:129–135PubMedCrossRef Ratnasinghe D, Tangrea JA, Forman MR, et al (2000) Serum tocopherols, selenium and lung cancer risk among tin miners in China. Cancer Causes Control 11:129–135PubMedCrossRef
106.
Zurück zum Zitat Reid ME, Duffield-Lillico AJ, Garland L, Turnbull BW, Clark LC, Marshall JR (2002) Selenium supplementation and lung cancer incidence: an update of the nutritional prevention of cancer trial. Cancer Epidemiol Biomark Prev 11:1285–1291 Reid ME, Duffield-Lillico AJ, Garland L, Turnbull BW, Clark LC, Marshall JR (2002) Selenium supplementation and lung cancer incidence: an update of the nutritional prevention of cancer trial. Cancer Epidemiol Biomark Prev 11:1285–1291
107.
Zurück zum Zitat Hartman TJ, Taylor PR, Alfthan G, et al (2002) Toenail selenium concentration and lung cancer in male smokers. Cancer Causes Control 13:923–928PubMedCrossRef Hartman TJ, Taylor PR, Alfthan G, et al (2002) Toenail selenium concentration and lung cancer in male smokers. Cancer Causes Control 13:923–928PubMedCrossRef
108.
Zurück zum Zitat van den Brandt PA, Goldbohm RA, van’t Veer P, et al (1993) A prospective study on selenium status and the risk of lung cancer. Cancer Res 53:4860–4865PubMed van den Brandt PA, Goldbohm RA, van’t Veer P, et al (1993) A prospective study on selenium status and the risk of lung cancer. Cancer Res 53:4860–4865PubMed
109.
Zurück zum Zitat Nakaji S, Fukuda S, Sakamoto J, et al (2001) Relationship between mineral and trace element concentrations in drinking water and gastric cancer mortality in Japan. Nutr Cancer 40:99–102PubMedCrossRef Nakaji S, Fukuda S, Sakamoto J, et al (2001) Relationship between mineral and trace element concentrations in drinking water and gastric cancer mortality in Japan. Nutr Cancer 40:99–102PubMedCrossRef
110.
Zurück zum Zitat Kneller RW, Guo WD, Hsing AW, et al (1992) Risk factors for stomach cancer in sixty-five Chinese counties. Cancer Epidemiol Biomark Prev 1:113–118 Kneller RW, Guo WD, Hsing AW, et al (1992) Risk factors for stomach cancer in sixty-five Chinese counties. Cancer Epidemiol Biomark Prev 1:113–118
111.
Zurück zum Zitat Chen SY, Liu TY, Shun CT, et al (2004) Modification effects of GSTM1, GSTT1 and CYP2E1 polymorphisms on associates between raw salted food and incomplete intestinal metaplasia in a high-risk area of stomach cancer. Int J Cancer 108:606–612PubMedCrossRef Chen SY, Liu TY, Shun CT, et al (2004) Modification effects of GSTM1, GSTT1 and CYP2E1 polymorphisms on associates between raw salted food and incomplete intestinal metaplasia in a high-risk area of stomach cancer. Int J Cancer 108:606–612PubMedCrossRef
112.
Zurück zum Zitat Zhang L, Blot WJ, You WC, et al (1994) Serum micronutrients in relation to pre-cancerous gastric lesions. Int J Cancer 56:650–654PubMed Zhang L, Blot WJ, You WC, et al (1994) Serum micronutrients in relation to pre-cancerous gastric lesions. Int J Cancer 56:650–654PubMed
113.
Zurück zum Zitat Knekt P, Aromaa A, Maatela J, et al (1990) Serum selenium and subsequent risk of cancer among Finnish men and women. JNCI 82:864–868PubMed Knekt P, Aromaa A, Maatela J, et al (1990) Serum selenium and subsequent risk of cancer among Finnish men and women. JNCI 82:864–868PubMed
114.
Zurück zum Zitat Wei WQ, Abnet CC, Qiao YL, et al (2004) Prospective study of serum selenium concentrations and esophageal and gastric cardia cancer, heart disease, stroke, and total death. Am J Clin Nutr 79:80–85PubMed Wei WQ, Abnet CC, Qiao YL, et al (2004) Prospective study of serum selenium concentrations and esophageal and gastric cardia cancer, heart disease, stroke, and total death. Am J Clin Nutr 79:80–85PubMed
115.
Zurück zum Zitat Mark SD, Qiao YL, Dawsey SM, et al (2000) Prospective study of serum selenium levels and incident esophageal and gastric cancers. J Natl Cancer Inst 92:1753–1763PubMedCrossRef Mark SD, Qiao YL, Dawsey SM, et al (2000) Prospective study of serum selenium levels and incident esophageal and gastric cancers. J Natl Cancer Inst 92:1753–1763PubMedCrossRef
116.
Zurück zum Zitat Dawsey SM, Wang GQ, Taylor PR, et al (1994) Effects of vitamin/mineral supplementation on the prevalence of histological dysplasia and early cancer of the esophagus and stomach: results from the Dysplasia Trial in Linxian, China. Cancer Epidemiol Biomark Prev 3:167–172 Dawsey SM, Wang GQ, Taylor PR, et al (1994) Effects of vitamin/mineral supplementation on the prevalence of histological dysplasia and early cancer of the esophagus and stomach: results from the Dysplasia Trial in Linxian, China. Cancer Epidemiol Biomark Prev 3:167–172
117.
Zurück zum Zitat Wang GQ, Dawsey SM, Li JY, et al (1994) Effects of vitamin/mineral supplementation on the prevalence of histological dysplasia and early cancer of the esophagus and stomach: results from the General Population Trial in Linxian, China. Cancer Epidemiol Biomark Prev 3:161–166 Wang GQ, Dawsey SM, Li JY, et al (1994) Effects of vitamin/mineral supplementation on the prevalence of histological dysplasia and early cancer of the esophagus and stomach: results from the General Population Trial in Linxian, China. Cancer Epidemiol Biomark Prev 3:161–166
118.
Zurück zum Zitat Helzlsouer KJ, Comstock GW, Morris JS (1989) Selenium, lycopene, alpha-tocopherol, beta-carotene, retinol, and subsequent bladder cancer. Cancer Res 49:6144–6148PubMed Helzlsouer KJ, Comstock GW, Morris JS (1989) Selenium, lycopene, alpha-tocopherol, beta-carotene, retinol, and subsequent bladder cancer. Cancer Res 49:6144–6148PubMed
119.
Zurück zum Zitat Zeegers MP, Goldbohm A, Bode P, van den Brandt PA (2002) Prediagnostic toenail selenium and risk of bladder cancer. Cancer Epidemiol Biomark Prev 11:1292–1297 Zeegers MP, Goldbohm A, Bode P, van den Brandt PA (2002) Prediagnostic toenail selenium and risk of bladder cancer. Cancer Epidemiol Biomark Prev 11:1292–1297
120.
Zurück zum Zitat Michaud DS, Hartman TJ, Taylor PR, et al (2002) No association between toenail selenium levels and bladder cancer risk. Cancer Epidemiol Biomark Prev 11:1505–1506 Michaud DS, Hartman TJ, Taylor PR, et al (2002) No association between toenail selenium levels and bladder cancer risk. Cancer Epidemiol Biomark Prev 11:1505–1506
121.
Zurück zum Zitat Vogt TM, Ziegler RG, Graubard BI, et al (2003) Serum selenium and risk of prostate cancer in US blacks and whites. Int J Cancer 103:664–670PubMedCrossRef Vogt TM, Ziegler RG, Graubard BI, et al (2003) Serum selenium and risk of prostate cancer in US blacks and whites. Int J Cancer 103:664–670PubMedCrossRef
122.
Zurück zum Zitat Allen NE, Morris JS, Ngwenyama RA, Key TJ (2004) A case–control study of selenium in nails and prostate cancer risk in British men. Br J Cancer 90:1392–1396PubMedCrossRef Allen NE, Morris JS, Ngwenyama RA, Key TJ (2004) A case–control study of selenium in nails and prostate cancer risk in British men. Br J Cancer 90:1392–1396PubMedCrossRef
123.
Zurück zum Zitat Brooks JD, Metter EJ, Chan DW, et al (2001) Plasma selenium level before diagnosis and the risk of prostate cancer development. J Urol 166: 2034–2038PubMedCrossRef Brooks JD, Metter EJ, Chan DW, et al (2001) Plasma selenium level before diagnosis and the risk of prostate cancer development. J Urol 166: 2034–2038PubMedCrossRef
124.
Zurück zum Zitat Helzlsouer KJ, Huang HY, Alberg AJ, et al (2000) Association between alpha-tocopherol, gamma-tocopherol, selenium, and subsequent prostate cancer. J Natl Cancer Inst 92:2018–2023PubMedCrossRef Helzlsouer KJ, Huang HY, Alberg AJ, et al (2000) Association between alpha-tocopherol, gamma-tocopherol, selenium, and subsequent prostate cancer. J Natl Cancer Inst 92:2018–2023PubMedCrossRef
125.
Zurück zum Zitat Nomura AMY, Lee J, Stemmermann GN, Combs GF Jr (2000) Serum selenium and subsequent risk of prostate cancer. Cancer Epidemiol Biomark Prev 9:883–887 Nomura AMY, Lee J, Stemmermann GN, Combs GF Jr (2000) Serum selenium and subsequent risk of prostate cancer. Cancer Epidemiol Biomark Prev 9:883–887
126.
Zurück zum Zitat Yoshizawa K, Willett WC, Morris SJ, et al (1998) Study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer. JNCI 90:1219–1224PubMedCrossRef Yoshizawa K, Willett WC, Morris SJ, et al (1998) Study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer. JNCI 90:1219–1224PubMedCrossRef
127.
Zurück zum Zitat Li H, Stampfer MJ, Giovannucci EL, et al (2004) A prospective study of plasma selenium levels and prostate cancer risk. J Natl Cancer Inst 96:696–703PubMedCrossRef Li H, Stampfer MJ, Giovannucci EL, et al (2004) A prospective study of plasma selenium levels and prostate cancer risk. J Natl Cancer Inst 96:696–703PubMedCrossRef
128.
Zurück zum Zitat van den Brandt PA, Zeegers MPA, Bode P, Goldbohm RA (2003) Toenail selenium levels and the subsequent risk of prostate cancer: a prospective cohort study. Cancer Epidemiol Biomark Prev 12:866–871 van den Brandt PA, Zeegers MPA, Bode P, Goldbohm RA (2003) Toenail selenium levels and the subsequent risk of prostate cancer: a prospective cohort study. Cancer Epidemiol Biomark Prev 12:866–871
129.
Zurück zum Zitat Hartman TJ, Albanes D, Pietinen P, et al (1998) The association between baseline vitamin E, selenium, and prostate cancer in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Cancer Epidemiol Biomark Prev 7:335–340 Hartman TJ, Albanes D, Pietinen P, et al (1998) The association between baseline vitamin E, selenium, and prostate cancer in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Cancer Epidemiol Biomark Prev 7:335–340
130.
Zurück zum Zitat Clark LC, Dalkin B, Krongrad A, et al (1998) Decreased incidence of prostate cancer with selenium supplementation: results of a double-blind cancer prevention trial. Br J Urol 81:730–734PubMed Clark LC, Dalkin B, Krongrad A, et al (1998) Decreased incidence of prostate cancer with selenium supplementation: results of a double-blind cancer prevention trial. Br J Urol 81:730–734PubMed
131.
Zurück zum Zitat Prasad AS, Halsted JA, Nadimi M (1961) Syndrome of iron deficiency anemia, hepatospenomegaly, hyopgonadism, dwarfism,and geophagia. Am J Med 31:532–546PubMedCrossRef Prasad AS, Halsted JA, Nadimi M (1961) Syndrome of iron deficiency anemia, hepatospenomegaly, hyopgonadism, dwarfism,and geophagia. Am J Med 31:532–546PubMedCrossRef
132.
Zurück zum Zitat Prasad AS, Miale A, Farid Z, Sandstead HH, Schulert AR (1963) Zinc metabolism in patients with the syndrome of iron deficiency anemia, hypogonadism and dwarfism. J Lab Clin Med 61:537–549PubMed Prasad AS, Miale A, Farid Z, Sandstead HH, Schulert AR (1963) Zinc metabolism in patients with the syndrome of iron deficiency anemia, hypogonadism and dwarfism. J Lab Clin Med 61:537–549PubMed
133.
Zurück zum Zitat Prasad AS (1998) Zinc in human health: an update. J Trace Elem Exp Med 11:63–78CrossRef Prasad AS (1998) Zinc in human health: an update. J Trace Elem Exp Med 11:63–78CrossRef
134.
135.
Zurück zum Zitat Leccia MT, Richard MJ, Favier A, Beani JC (1999) Zinc protects against ultraviolet A1-induced DNA damage and apoptosis in cultured human fibroblasts. Biol Trace Elem Res 69:177–190PubMed Leccia MT, Richard MJ, Favier A, Beani JC (1999) Zinc protects against ultraviolet A1-induced DNA damage and apoptosis in cultured human fibroblasts. Biol Trace Elem Res 69:177–190PubMed
136.
Zurück zum Zitat Gupta SK, Shukla VK, Vaidya MP, Roy SK, Gupta S (1991) Serum trace elements and Cu/Zn ratio in breast cancer patients. J Surg Oncol 46:178–181PubMed Gupta SK, Shukla VK, Vaidya MP, Roy SK, Gupta S (1991) Serum trace elements and Cu/Zn ratio in breast cancer patients. J Surg Oncol 46:178–181PubMed
137.
Zurück zum Zitat Adzersen KH, Jess P, Freivogel KW, Gerhard I, Bastert G (2003) Raw and cooked vegetables, fruits, selected micronutrients, and breast cancer risk: a case–control study in Germany. Nutr Cancer 46:131–137PubMedCrossRef Adzersen KH, Jess P, Freivogel KW, Gerhard I, Bastert G (2003) Raw and cooked vegetables, fruits, selected micronutrients, and breast cancer risk: a case–control study in Germany. Nutr Cancer 46:131–137PubMedCrossRef
138.
Zurück zum Zitat Harris RWC, Key TJA, Silcocks PB, Bull D, Wald NJ (1991) A case–control study of dietary carotene in men with lung cancer and in men with other epithelial cancers. Nutr Cancer 15:63–68PubMed Harris RWC, Key TJA, Silcocks PB, Bull D, Wald NJ (1991) A case–control study of dietary carotene in men with lung cancer and in men with other epithelial cancers. Nutr Cancer 15:63–68PubMed
139.
Zurück zum Zitat Cocco PL, Carta P, Belli S, Picchiri GF, Flore MV (1994) Mortality of Sardinian lead and zinc miners: 1960–88. Occup Environ Med 51:674–682PubMedCrossRef Cocco PL, Carta P, Belli S, Picchiri GF, Flore MV (1994) Mortality of Sardinian lead and zinc miners: 1960–88. Occup Environ Med 51:674–682PubMedCrossRef
140.
Zurück zum Zitat Zhang ZF, Kurtz RC, Yu GP, et al (1997) Adenocarcinomas of the esophagus and gastric cardia: the role of diet. Nutr Cancer 27:298–309PubMed Zhang ZF, Kurtz RC, Yu GP, et al (1997) Adenocarcinomas of the esophagus and gastric cardia: the role of diet. Nutr Cancer 27:298–309PubMed
141.
Zurück zum Zitat Costello LC, Franklin RB, Tan M, Bagasra O (2005) Zinc and prostate cancer: a critical scientific, medical, and public interest issue (United States). Cancer Causes Control 16:901–915PubMedCrossRef Costello LC, Franklin RB, Tan M, Bagasra O (2005) Zinc and prostate cancer: a critical scientific, medical, and public interest issue (United States). Cancer Causes Control 16:901–915PubMedCrossRef
142.
Zurück zum Zitat Kolonel LN, Yoshizawa CN, Hankin JH (1988) Diet and prostatic cancer: a case–control study in Hawaii. Am J Epidemiol 127:999–1012PubMed Kolonel LN, Yoshizawa CN, Hankin JH (1988) Diet and prostatic cancer: a case–control study in Hawaii. Am J Epidemiol 127:999–1012PubMed
143.
Zurück zum Zitat Leitzmann MF, Stampfer MJ, Wu K, Colditz GA, Willett WC, Giovannucci EL (2003) Zinc supplement use and risk of prostate cancer. J Natl Cancer Inst 95:1004–1007PubMed Leitzmann MF, Stampfer MJ, Wu K, Colditz GA, Willett WC, Giovannucci EL (2003) Zinc supplement use and risk of prostate cancer. J Natl Cancer Inst 95:1004–1007PubMed
144.
Zurück zum Zitat Kristal AR, Stanford JL, Cohen JH, Wicklund K, Patterson RE (1999) Vitamin and mineral supplement use is associated with reduced risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 8:887–892PubMed Kristal AR, Stanford JL, Cohen JH, Wicklund K, Patterson RE (1999) Vitamin and mineral supplement use is associated with reduced risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 8:887–892PubMed
145.
Zurück zum Zitat Vlajinac HD, Marinkovic JM, Ilic MD, Kocev NI (1997) Diet and prostate cancer: a case–control study. Eur J Nutr 33:101–107 Vlajinac HD, Marinkovic JM, Ilic MD, Kocev NI (1997) Diet and prostate cancer: a case–control study. Eur J Nutr 33:101–107
Metadaten
Titel
Trace elements and cancer risk: a review of the epidemiologic evidence
verfasst von
Stephanie A. Navarro Silvera
Thomas E. Rohan
Publikationsdatum
01.02.2007
Verlag
Kluwer Academic Publishers
Erschienen in
Cancer Causes & Control / Ausgabe 1/2007
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-006-0057-z

Weitere Artikel der Ausgabe 1/2007

Cancer Causes & Control 1/2007 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.